Gui‐Ling Chen
Impact in
- Pharmaceutical Science top 10%
- Fluorine in Organic Chemistry
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Hepatitis C virus research 3
-
- Biosimilars and Bioanalytical Methods 4
- Co-authors
- Junlei Wang (3 shared papers)Binbin Huang (3 shared papers)Hong Zhang (9 shared papers)Rui Pan (3 shared papers)Jun Dong (3 shared papers)Junqi Niu (7 shared papers)Sisi Liu (3 shared papers)Guangming Li (3 shared papers)
- Journals
- Frontiers in Pharmacology (4 papers)Diagnostic Microbiology and Infectious Disease (1 paper)Vaccine (1 paper)ACS Omega (1 paper)Hepatology International (1 paper)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Gui‐Ling Chen
33 papers receiving 399 citations
Peers
Comparison fields: 5 of 63
- Pharmaceutical Science 43
- Hepatology 27
- Complementary and alternative medicine 23
- Immunology 47
- Neurology 18
Countries citing papers authored by Gui‐Ling Chen
This map shows the geographic impact of Gui‐Ling Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gui‐Ling Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gui‐Ling Chen more than expected).
Fields of papers citing papers by Gui‐Ling Chen
This network shows the impact of papers produced by Gui‐Ling Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gui‐Ling Chen. The network helps show where Gui‐Ling Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Gui‐Ling Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 58 | |
| 2 | 2018 | 37 | |
| 3 | 2023 | 29 | |
| 4 | 2018 | 28 | |
| 5 | 2019 | 28 | |
| 6 | 2020 | 26 | |
| 7 | 2019 | 25 | |
| 8 | 2021 | 20 | |
| 9 | 2018 | 17 | |
| 10 | 2018 | 17 | |
| 11 | 2022 | 12 | |
| 12 | 2022 | 12 | |
| 13 | 2019 | 11 | |
| 14 | 2017 | 10 | |
| 15 | 2017 | 9 | |
| 16 | 2019 | 8 | |
| 17 | 2023 | 8 | |
| 18 | 2018 | 7 | |
| 19 | 2023 | 6 | |
| 20 | 2023 | 6 |
About Gui‐Ling Chen
Gui‐Ling Chen is a scholar working on Hepatology, Immunology, Infectious Diseases, Pediatrics, Perinatology and Child Health and Neurology, having authored 37 papers that have together received 413 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (4 papers), Hepatitis C virus research (3 papers), Pharmaceutical studies and practices (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Mesenchymal stem cell research (2 papers), Autophagy in Disease and Therapy (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). The work is most often cited by research in Pharmaceutical Science (43 citations), Hepatology (27 citations), Complementary and alternative medicine (23 citations), Immunology (47 citations) and Neurology (18 citations). Gui‐Ling Chen has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Junlei Wang, Binbin Huang, Hong Zhang, Rui Pan, Jun Dong, Junqi Niu, Sisi Liu, Guangming Li, Hong-Qing Li and Xiaodong Cai. Their work appears in journals such as Frontiers in Pharmacology, Diagnostic Microbiology and Infectious Disease, Vaccine, ACS Omega and Hepatology International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.